Literature DB >> 18698162

Vessel normalization by VEGF inhibition. A complex story.

An Claes1, William Leenders.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698162     DOI: 10.4161/cbt.7.7.6474

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  5 in total

1.  Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.

Authors:  Bob Hamans; Anna Catharina Navis; Alan Wright; Pieter Wesseling; Arend Heerschap; William Leenders
Journal:  Neuro Oncol       Date:  2013-10-24       Impact factor: 12.300

2.  Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296.

Authors:  Elise Langenkamp; Peter J Zwiers; Henk E Moorlag; William P Leenders; Brad St Croix; Grietje Molema
Journal:  Anticancer Drugs       Date:  2012-02       Impact factor: 2.248

3.  Effects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2.

Authors:  Anna C Navis; Annika Bourgonje; Pieter Wesseling; Alan Wright; Wiljan Hendriks; Kiek Verrijp; Jeroen A W M van der Laak; Arend Heerschap; William P J Leenders
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

4.  MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog.

Authors:  Jin-Kyung Seok; Sun Hee Lee; Min Jung Kim; You-Mie Lee
Journal:  Nucleic Acids Res       Date:  2014-06-09       Impact factor: 16.971

5.  Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.

Authors:  Sanne A M van Lith; Anna C Navis; Krissie Lenting; Kiek Verrijp; Jan T G Schepens; Wiljan J A J Hendriks; Nil A Schubert; Hanka Venselaar; Ron A Wevers; Arno van Rooij; Pieter Wesseling; Remco J Molenaar; Cornelis J F van Noorden; Stefan Pusch; Bastiaan Tops; William P J Leenders
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.